In this context, it would be of interest to investigate whether miR-34a, a miRNA that is known to act as a translational repressor of SIRT mRNA, and to be upregulated in SSc patients [61], might be responsible for a decrease in SIRT1 and SIRT3 levels in the circulation of SSc patients. The gene discussed is SIRT3; the disease is systemic sclerosis.